牛皮癣-话题@MedSci

#牛皮癣#

49篇内容 | 1469人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1321097, encodeId=193b132109ec6, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=J Immunother Cancer：免疫检查点抑制剂在伴有牛皮癣患者的疗效和安全性, objectType=article, longId=218548, objectId=8a8921854861, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a8921854861, replyNumber=0, likeNumber=48, createdTime=2021-10-15, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a8921854861, moduleTitle=J Immunother Cancer：免疫检查点抑制剂在伴有牛皮癣患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a8921854861)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321096, encodeId=9c7f1321096a4, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=III期数据证明：IL-23单抗TREMFYA可连续5年，维持斑块状牛皮癣患者的皮肤清除率, objectType=article, longId=202204, objectId=7085202204a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7085202204a8, replyNumber=0, likeNumber=45, createdTime=2020-10-18, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7085202204a8, moduleTitle=III期数据证明：IL-23单抗TREMFYA可连续5年，维持斑块状牛皮癣患者的皮肤清除率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7085202204a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321095, encodeId=4c5113210950a, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=Science Advances：RNA疗法结合创新递送技术，让牛皮癣不再“牛”, objectType=article, longId=201116, objectId=eae820111640, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eae820111640, replyNumber=0, likeNumber=46, createdTime=2020-09-25, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eae820111640, moduleTitle=Science Advances：RNA疗法结合创新递送技术，让牛皮癣不再“牛”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eae820111640)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321094, encodeId=7dfd132109491, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=诺华IL-17A单抗Cosentyx：获欧盟批准一线治疗牛皮癣儿童患者, objectType=article, longId=198732, objectId=59fb198e32ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59fb198e32ce, replyNumber=0, likeNumber=48, createdTime=2020-08-06, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59fb198e32ce, moduleTitle=诺华IL-17A单抗Cosentyx：获欧盟批准一线治疗牛皮癣儿童患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59fb198e32ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321093, encodeId=62f3132109393, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=IL-12/IL-23单抗Stelara（ustekinumab），获得FDA批准治疗牛皮癣儿童患者, objectType=article, longId=198548, objectId=231019854869, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=231019854869, replyNumber=0, likeNumber=36, createdTime=2020-08-03, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=231019854869, moduleTitle=IL-12/IL-23单抗Stelara（ustekinumab），获得FDA批准治疗牛皮癣儿童患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=231019854869)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321092, encodeId=389f1321092ce, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=牛皮癣III期临床：礼来的IL-23单抗mirikizumab优于诺华的IL-17A单抗Cosentyx, objectType=article, longId=197732, objectId=5be919e73267, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5be919e73267, replyNumber=0, likeNumber=23, createdTime=2020-07-20, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5be919e73267, moduleTitle=牛皮癣III期临床：礼来的IL-23单抗mirikizumab优于诺华的IL-17A单抗Cosentyx, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5be919e73267)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321091, encodeId=378a132109178, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=NEJM：罗氟司特局部乳膏治疗慢性斑块状牛皮癣的2b期阳性结果, objectType=article, longId=197622, objectId=ae3b19e62262, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae3b19e62262, replyNumber=0, likeNumber=45, createdTime=2020-07-18, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae3b19e62262, moduleTitle=NEJM：罗氟司特局部乳膏治疗慢性斑块状牛皮癣的2b期阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae3b19e62262)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321090, encodeId=77431321090bd, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=抗体药物偶联物ILUMYA（tildrakizumab-asmn）治疗中重度斑块状牛皮癣：长期安全性有效性良好, objectType=article, longId=195863, objectId=9d4319586365, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d4319586365, replyNumber=0, likeNumber=35, createdTime=2020-06-15, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d4319586365, moduleTitle=抗体药物偶联物ILUMYA（tildrakizumab-asmn）治疗中重度斑块状牛皮癣：长期安全性有效性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d4319586365)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321089, encodeId=f4dc132108994, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=AAD 2020：3期临床证实IL-17A/IL-17F单抗Bimekizumab治疗牛皮癣，优于IL-12/IL-23单抗ustekinumab, objectType=article, longId=195839, objectId=0f4c19583900, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f4c19583900, replyNumber=0, likeNumber=34, createdTime=2020-06-15, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f4c19583900, moduleTitle=AAD 2020：3期临床证实IL-17A/IL-17F单抗Bimekizumab治疗牛皮癣，优于IL-12/IL-23单抗ustekinumab, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f4c19583900)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321088, encodeId=9c6e132108877, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=Otezla（apremilast）治疗轻中度斑块型牛皮癣的III期ADVANCE研究：取得积极结果, objectType=article, longId=193626, objectId=9c621936262c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c621936262c, replyNumber=0, likeNumber=37, createdTime=2020-05-08, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c621936262c, moduleTitle=Otezla（apremilast）治疗轻中度斑块型牛皮癣的III期ADVANCE研究：取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c621936262c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321087, encodeId=4e0f132108e31, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=被英国NICE拒绝后，强生的IL-23/IL-12单抗Stelara获得欧盟扩展适应症治疗儿童牛皮癣, objectType=article, longId=187183, objectId=a1b618e18333, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1b618e18333, replyNumber=0, likeNumber=41, createdTime=2020-02-03, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1b618e18333, moduleTitle=被英国NICE拒绝后，强生的IL-23/IL-12单抗Stelara获得欧盟扩展适应症治疗儿童牛皮癣, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1b618e18333)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321086, encodeId=2a961321086d9, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=卡泊三醇喷雾剂治疗牛皮癣的III期临床取得阳性结果, objectType=article, longId=186746, objectId=f965186e4626, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f965186e4626, replyNumber=0, likeNumber=53, createdTime=2020-01-27, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f965186e4626, moduleTitle=卡泊三醇喷雾剂治疗牛皮癣的III期临床取得阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f965186e4626)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321085, encodeId=9eec1321085af, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=头对头牛皮癣临床研究，艾伯维的IL-23单抗Skyrizi显着优于诺华的IL-17单抗Cosentyx, objectType=article, longId=186385, objectId=ced718638553, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ced718638553, replyNumber=0, likeNumber=41, createdTime=2020-01-18, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ced718638553, moduleTitle=头对头牛皮癣临床研究，艾伯维的IL-23单抗Skyrizi显着优于诺华的IL-17单抗Cosentyx, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ced718638553)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321084, encodeId=76e91321084fa, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=Sci Adv：让牛皮癣不再牛！新方法可诱导实现牛皮癣迅速消失, objectType=article, longId=186238, objectId=c6ea186238ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6ea186238ea, replyNumber=0, likeNumber=42, createdTime=2020-01-16, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6ea186238ea, moduleTitle=Sci Adv：让牛皮癣不再牛！新方法可诱导实现牛皮癣迅速消失, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6ea186238ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321083, encodeId=756b1321083ee, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=头对头III期牛皮癣研究证实，UCB的IL-17A / IL-17F单抗bimekizumab优于AbbVie的TNF单抗Humira, objectType=article, longId=184396, objectId=e1d618439611, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1d618439611, replyNumber=0, likeNumber=34, createdTime=2019-12-09, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1d618439611, moduleTitle=头对头III期牛皮癣研究证实，UCB的IL-17A / IL-17F单抗bimekizumab优于AbbVie的TNF单抗Humira, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1d618439611)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321082, encodeId=dce913210822f, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=头对头牛皮癣研究中，礼来的IL-17A单抗Taltz与强生的IL-23单抗Tremfya相比可提高皮肤清除率, objectType=article, longId=180571, objectId=711e1805e121, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=711e1805e121, replyNumber=0, likeNumber=42, createdTime=2019-10-07, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=711e1805e121, moduleTitle=头对头牛皮癣研究中，礼来的IL-17A单抗Taltz与强生的IL-23单抗Tremfya相比可提高皮肤清除率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=711e1805e121)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321081, encodeId=c0f0132108164, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=诺华的牛皮癣药物IL-17单抗Cosentyx在国内获批上市, objectType=article, longId=163639, objectId=30a2163639f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30a2163639f7, replyNumber=0, likeNumber=44, createdTime=2019-04-06, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30a2163639f7, moduleTitle=诺华的牛皮癣药物IL-17单抗Cosentyx在国内获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30a2163639f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321080, encodeId=44a7132108083, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=Cosentyx治疗的牛皮癣患者最早可于4周出现生活质量指标改善, objectType=article, longId=159220, objectId=483f159220a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=483f159220a9, replyNumber=0, likeNumber=42, createdTime=2019-01-31, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=483f159220a9, moduleTitle=Cosentyx治疗的牛皮癣患者最早可于4周出现生活质量指标改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=483f159220a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321079, encodeId=5b6513210e93e, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=JAMA Dermat：可以通过饮食来改善牛皮癣症状吗？, objectType=article, longId=145725, objectId=3cc9145e250b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cc9145e250b, replyNumber=0, likeNumber=47, createdTime=2018-08-04, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cc9145e250b, moduleTitle=JAMA Dermat：可以通过饮食来改善牛皮癣症状吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cc9145e250b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1321078, encodeId=4c2813210e85b, content=<a href='/topic/show?id=2a136e77095' target=_blank style='color:#2F92EE;'>#牛皮癣#</a>, objectTitle=GSK将牛皮癣/皮炎治疗药物Tapinarof出售给Dermavant, objectType=article, longId=144473, objectId=bc551444e3dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc551444e3dc, replyNumber=0, likeNumber=43, createdTime=2018-07-16, rootId=0, userName=yangfl06, userId=1c2e485, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc551444e3dc, moduleTitle=GSK将牛皮癣/皮炎治疗药物Tapinarof出售给Dermavant, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc551444e3dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

牛皮癣

2020-05-29

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

J Immunother Cancer：免疫检查点抑制剂在伴有牛皮癣患者的疗效和安全性

2021-10-15

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

III期数据证明：IL-23单抗TREMFYA可连续5年，维持斑块状牛皮癣患者的皮肤清除率

2020-10-18

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

Science Advances：RNA疗法结合创新递送技术，让牛皮癣不再“牛”

2020-09-25

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

诺华IL-17A单抗Cosentyx：获欧盟批准一线治疗牛皮癣儿童患者

2020-08-06

hb2008ye (审核中...)

前往app查看评论内容

#牛皮癣#

IL-12/IL-23单抗Stelara（ustekinumab），获得FDA批准治疗牛皮癣儿童患者

2020-08-03

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

牛皮癣III期临床：礼来的IL-23单抗mirikizumab优于诺华的IL-17A单抗Cosentyx

2020-07-20

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

NEJM：罗氟司特局部乳膏治疗慢性斑块状牛皮癣的2b期阳性结果

2020-07-18

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

抗体药物偶联物ILUMYA（tildrakizumab-asmn）治疗中重度斑块状牛皮癣：长期安全性有效性良好

2020-06-15

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

AAD 2020：3期临床证实IL-17A/IL-17F单抗Bimekizumab治疗牛皮癣，优于IL-12/IL-23单抗ustekinumab

2020-06-15

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

Otezla（apremilast）治疗轻中度斑块型牛皮癣的III期ADVANCE研究：取得积极结果

2020-05-08

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

被英国NICE拒绝后，强生的IL-23/IL-12单抗Stelara获得欧盟扩展适应症治疗儿童牛皮癣

2020-02-03

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

卡泊三醇喷雾剂治疗牛皮癣的III期临床取得阳性结果

2020-01-27

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

头对头牛皮癣临床研究，艾伯维的IL-23单抗Skyrizi显着优于诺华的IL-17单抗Cosentyx

2020-01-18

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

Sci Adv：让牛皮癣不再牛！新方法可诱导实现牛皮癣迅速消失

2020-01-16

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

头对头III期牛皮癣研究证实，UCB的IL-17A / IL-17F单抗bimekizumab优于AbbVie的TNF单抗Humira

2019-12-09

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

头对头牛皮癣研究中，礼来的IL-17A单抗Taltz与强生的IL-23单抗Tremfya相比可提高皮肤清除率

2019-10-07

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

诺华的牛皮癣药物IL-17单抗Cosentyx在国内获批上市

2019-04-06

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

Cosentyx治疗的牛皮癣患者最早可于4周出现生活质量指标改善

2019-01-31

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

JAMA Dermat：可以通过饮食来改善牛皮癣症状吗？

2018-08-04

yangfl06 (审核中...)

前往app查看评论内容

#牛皮癣#

GSK将牛皮癣/皮炎治疗药物Tapinarof出售给Dermavant

2018-07-16

科室
- - 订阅+
  - 更多科室
工具
服务